All News
STAT+: What to watch on Akero’s MASH-cirrhosis study results next month
What to watch for when Akero Therapeutics reports MASH-cirrhosis study results next month.
Read MoreExThera Claimed Its Device Could Cure Cancer. But Patients Died.
Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American regulators.
Read MoreCovered California Hits Record Enrollment, but Key Subsidies in Jeopardy
Enhanced federal subsidies and more state aid for out-of-pocket costs have made health insurance purchased through California’s marketplace more affordable.
Read MoreTrump’s Early Health Moves Signal Intent To Erase Biden’s Legacy. What’s Next is Unclear.
President Donald Trump issued a flurry of executive orders and other actions on health care soon after reentering office.
Read MoreAs States Diverge on Immigration, Hospitals Say They Won’t Turn Patients Away
California and Massachusetts are teaching immigrants their rights while Florida and Texas are collecting patients’ immigration status.
Read MoreLegal overreaction to Supreme Court ban on race fueling loss of diversity at medical schools
Response to the court decision has been “overzealous,” say some experts, and there are still legal strategies that could diversify enrollment.
Read MoreTrump executive order declaring only ‘two sexes’ gets the biology wrong, scientists say
Trump executive order declaring two sexes defies decades of research into how human bodies grow and develop
Read MoreOpinion: Allowing ICE in hospitals is a public health catastrophe in the making
The Trump administration moved this week to end longstanding protections barring Immigration and Customs Enforcement (ICE) from conducting raids in hospitals and medical clinics.
Read MoreOpinion: ‘Rationing by inconvenience’: Health insurers count on customers not appealing denials
Call it “rationing by inconvenience”: Health insurers save money when customers are too exhausted to bother appealing denials.
Read MoreIndia’s pharma sector gathers for national GMP conference at medtech zone
Policymakers, industry leaders, and regulators gather at Andhra Pradesh MedTech Zone to discuss GMP’s role in pharma manufacturing
Read More